These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7146208)

  • 1. [Propranolol-Polfa in the treatment of schizophrenic psychoses].
    Sobkowiak J; Rymaszewski Z; Młyński J; Sznajderman M
    Psychiatr Pol; 1982; 16(1-2):59-65. PubMed ID: 7146208
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of propranolol treatment on serum prolactin level in schizophrenic patients.
    Elizur A; Segal Z; Yeret A; Ben-David M
    Commun Psychopharmacol; 1980; 4(3):203-6. PubMed ID: 7226751
    [No Abstract]   [Full Text] [Related]  

  • 3. Interictal psychoses in comparison with schizophrenia--a prospective study.
    Tadokoro Y; Oshima T; Kanemoto K
    Epilepsia; 2007 Dec; 48(12):2345-51. PubMed ID: 17666070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
    Metzer WS; Paige SR; Newton JE
    Mov Disord; 1993; 8(1):43-6. PubMed ID: 8093548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia.
    Levinson I; Levine S
    Biol Psychiatry; 1995 Aug; 38(3):198-200. PubMed ID: 7578667
    [No Abstract]   [Full Text] [Related]  

  • 8. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
    Kopala LC; Fredrikson D; Good KP; Honer WG
    Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
    [No Abstract]   [Full Text] [Related]  

  • 9. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol in schizophrenia. Clinical, metabolic, and pharmacological findings.
    Hanssen T; Heyden T; Sundberg I; Alfredsson G; Nybäck H; Wetterberg L
    Arch Gen Psychiatry; 1980 Jun; 37(6):685-90. PubMed ID: 7387339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of treatment of reflex algodystrophy of the limbs with propranolol-Polfa and griseofulvin].
    Gburek Z
    Reumatologia; 1983; 21(3-4):271-5. PubMed ID: 6369463
    [No Abstract]   [Full Text] [Related]  

  • 12. Active and passive avoidance learning in controls and schizophrenic patients on racemic propranolol and neuroleptics.
    Gruzelier J; Thornton S; Staniforth D; Zaki S; Yorkston N
    Br J Psychiatry; 1980 Aug; 137():131-7. PubMed ID: 6107137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of clinical usefulness of decaldol (haloperidol decanoate) produced by WZF Polfa in Warsaw in long-term treatment of schizophrenia].
    Morasiewicz J; Baranowski P; Borys J; Jańska-Skomorowska M; Kiejna A
    Psychiatr Pol; 1995; 29(3):405-20. PubMed ID: 7652093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial.
    Leiderman E; Zylberman I; Zukin SR; Cooper TB; Javitt DC
    Biol Psychiatry; 1996 Feb; 39(3):213-5. PubMed ID: 8837983
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug treatment of schizophrenic psychoses in puerperium].
    Olbrich HM; Martin P
    Nervenarzt; 1994 Jul; 65(7):482-5. PubMed ID: 7800093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
    Zink M; Knopf U; Henn FA; Thome J
    Pharmacopsychiatry; 2004 Jan; 37(1):26-31. PubMed ID: 14750045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of the adjuvant use of benzodiazepines for treating outpatients with schizophrenia.
    Pecknold JC
    J Psychiatry Neurosci; 1993 Mar; 18(2):82-4. PubMed ID: 8096393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of propranolol for provoked and unprovoked episodes of rage.
    Ratey JJ; Morrill R; Oxenkrug G
    Am J Psychiatry; 1983 Oct; 140(10):1356-7. PubMed ID: 6624970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in symptoms and plasma homovanillic acid with amantadine hydrochloride in chronic schizophrenia.
    Yamada K; Kanba S; Ohnishi K; Ashikari I; Yagi G; Asai M
    Biol Psychiatry; 1997 May; 41(10):1062-4. PubMed ID: 9129786
    [No Abstract]   [Full Text] [Related]  

  • 20. Is propranolol antischizophrenic?
    Peet M
    Neuropharmacology; 1981 Dec; 20(12B):1303-7. PubMed ID: 6119640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.